30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

STUART LEWIS J

Insider profile

STUART LEWIS J's trades of Cymabay Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-06 2024-02-06 PrS Proposed sale
24,253
421.56
US$3,863,402
24,253 421.56 US$3,863,402
2024-01-22 2024-01-22 PrS Proposed sale
42,011
64.38
US$1,866,076
42,011 64.38 US$1,866,076
2024-01-19 2024-01-19 PrS Proposed sale
16,830
80.48
US$1,834,453
16,830 80.48 US$1,834,453
2024-01-18 2024-01-18 PrS Proposed sale
60,749
23.40
US$1,421,527
60,749 23.40 US$1,421,527
2024-01-17 2024-01-17 PrS Proposed sale
40,158
23.40
US$939,697
40,158 23.40 US$939,697
2024-01-03 2024-01-03 PrS Proposed sale
337,583
24.25
US$8,186,388
337,583 24.25 US$8,186,388